Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature
Authors:
Open Access
- 1 January 2023
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Drug Safety
- Vol. 14
Abstract
The relatively new discipline of pharmacovigilance (PV) aims to monitor the safety of drugs throughout their evolution and is essential to discovering new drug risks. Due to their specific and complex physiology, children, pregnant women, and elderly adults are more prone to adverse drug reactions (ADRs). Additionally, the lack of clinical trial data exacerbates the challenges faced with pharmacotherapy in these populations. Elderly patients tend to have multiple comorbidities often requiring more extensive medication, which adds additional challenges for healthcare professionals (HCPs) in delivering safe and effective pharmacotherapy. Clinical trials often have inherent limitations, including insufficient sample size and limited duration of research; as some ADRs are attributed to long-term use of a drug, these may go undetected during the course of the trial. Therefore, the implementation of PV is key to insuring the safe and effective use of drugs in special populations. We conducted a thorough review of the scientific literature on PV systems across the European Union, the United States, and China. Our review focused on basic physiological characteristics, drug use, and PV for specific populations (children, pregnant women, and the elderly). This article aims to provide a reference for the development of follow-up policies and improvement of existing policies as well as provide insight into drug safety with respect to patients of special populations.Keywords
Funding Information
- the Chongqing Special Project for Technological Innovation and Application Development (NO. CSTC2021jscx-gksb-N0013)
- the Chongqing Clinical Pharmacy Key Specialties Construction Project
This publication has 112 references indexed in Scilit:
- Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children – a prospective observational cohort study of 6,601 admissionsBMC Medicine, 2013
- Adverse Health Outcomes in Women Exposed In Utero to DiethylstilbestrolNew England Journal of Medicine, 2011
- Evolving knowledge of the teratogenicity of medications in human pregnancyAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008American Journal of Obstetrics and Gynecology, 2011
- Understanding Developmental PharmacodynamicsPediatric Drugs, 2010
- The history and contemporary challenges of the US Food and Drug AdministrationClinical Therapeutics, 2007
- Comparative Performance of Two Quantitative Safety Signalling MethodsDrug Safety, 2006
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004
- Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and ChildrenNew England Journal of Medicine, 2003
- Quantitative Methods in PharmacovigilanceDrug Safety, 2003